ArthroCare Corporation (ARTC)
News
| May 17 | ArthroCare Corp. Enters Oversold Territory |
| May 17 | Piper Jaffray Starts ArthroCare (ARTC) at Overweight Street Insider |
| May 16 | MAKO Entangled in Lawsuits |
| May 10 | 6 Cash Heavy Small-Cap Healthcare Stocks Rated As Buys |
| May 07 | ArthroCare Beats on Both Top and Bottom Lines Fool |
| May 07 | Zacks #1 Rank Additions for Monday |
| May 04 | Company Profile for ArthroCare Corporation Business Wire |
| May 03 | $ARTC Volume Alert - Currently at 5 x average daily volume. by TradeIdeasQuant |
| May 03 | ArthroCare Earnings Call scheduled for 8:30 am ET today |
| May 03 | Listen to $ARTC Q1 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3e12 by earningscast |
| Apr 03 | $ARTC filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3CTF by MarketBrief |
| Mar 27 | $ARTC http://stks.co/35ni long setup by stt2318 |
| Mar 16 | $ARTC has big gap to fill if it breaks out. by DeeLee |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Medical Appliances & Equipment
ArthroCare develops and manufactures surgical devices, instruments, and implants that strive to enhance surgical techniques as well as improve patient outcomes. Its devices improve many existing surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its internationally patented Coblation® technology. This technology precisely dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology including its OPUS® line of fixation products as well as re-usable surgical instruments. ArthroCare is leveraging these technologies in order to offer a comprehensive line of surgical devices to capitalize on a multi-billion dollar market opportunity across several surgical specialties, including its two core product areas consisting of Sports Medicine and Ear, Nose, and Throat as well as other areas such as spine, wound care, urology and gynecology. The company was founded on April 29, 1993 and is headquartered in Austin, Texas.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). ArthroCare Corporation is down 23.36% over the last year vs S&P 500 Total Return up 1.62%, MAKO Surgical down 30.51%, and Given Imaging down 22.91%.
- ARTC Total Returns
- ^SPXTR Total Returns
- MAKO Total Returns
- GIVN Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these ARTC related companies
Pro Strategies Featuring ARTC
Did ArthroCare Corporation make it into our Pro Portfolio Strategies?
ARTC Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other ARTC Resources
- Company Website
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| ARTC | 26.44 | +0.93 | +3.65% | 729.48M |
| ART | 3.02 | +0.01 | +0.33% | 176.01M |
| ARSD | 10.12 | -0.18 | -1.75% | 240.25M |
| ARRY | 3.46 | -0.19 | -5.21% | 282.16M |
| ARRS | 12.32 | -0.01 | -0.08% | 1.418B |
| ARR | 6.95 | +0.05 | +0.72% | 984.88M |
| ARQL | 5.87 | +0.05 | +0.86% | 316.69M |
| AROW | 23.85 | -0.05 | -0.21% | 283.82M |
| ARO | 19.19 | +0.17 | +0.89% | 1.554B |
| ARNA | 6.00 | -0.04 | -0.66% | 1.083B |
